Skip to content
Twitter Linkedin
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
      • Filing in the US
      • Regulatory Affairs | UK and Europe
      • CMC Regulatory Affairs
      • Medical Devices
      • SME Status via Boyds
    • Clinical and Medical Affairs
      • Interim Chief Medical Officer
      • Medical Monitoring
      • Scientific and Medical Advice
      • Support for Medical Directors and Chief Medical Officers
      • Meet the Medics
    • Clinical Operations
      • Biostatistics
      • Clinical Project Management
      • Clinical Site Monitoring
      • Clinical Study Start-Up
    • Pharmaceutical Due Diligence
    • Product Development
      • Investor Readiness
    • Regulatory Operations and Publishing
      • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Early Access Programs and Real-World Data Collection
    • My Development TEAM
  • Latest
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast | Conversations in Drug Development
  • Regulatory Updates
  • Resources
    • Factsheets
    • Publications
    • Webinars
  • Contact us
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
      • Filing in the US
      • Regulatory Affairs | UK and Europe
      • CMC Regulatory Affairs
      • Medical Devices
      • SME Status via Boyds
    • Clinical and Medical Affairs
      • Interim Chief Medical Officer
      • Medical Monitoring
      • Scientific and Medical Advice
      • Support for Medical Directors and Chief Medical Officers
      • Meet the Medics
    • Clinical Operations
      • Biostatistics
      • Clinical Project Management
      • Clinical Site Monitoring
      • Clinical Study Start-Up
    • Pharmaceutical Due Diligence
    • Product Development
      • Investor Readiness
    • Regulatory Operations and Publishing
      • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Early Access Programs and Real-World Data Collection
    • My Development TEAM
  • Latest
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast | Conversations in Drug Development
  • Regulatory Updates
  • Resources
    • Factsheets
    • Publications
    • Webinars
  • Contact us
Boyds Home
Linkedin X-twitter Spotify Youtube
  • Home
  • About

    About Boyds

    A global drug development consultancy supporting cutting-edge development.

    Find out more
    • Why Boyds
    • Our Team
    • Vision and Values
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
    • Filing in the US
    • Filing in the UK & Europe
    • CMC Regulatory Affairs
    • Medical Devices
    • SME Status via Boyds
    • Filing in the US
    • Filing in the UK & Europe
    • CMC Regulatory Affairs
    • Medical Devices
    • SME Status via Boyds
    • Regulatory Operations and Submissions Support
    • Regulatory Submission Pathways
    • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Clinical and Medical Affairs
    • Interim Chief Medical Officer
    • Medical Monitoring
    • Scientific and Medical Advice
    • Support for Medical Directors and Chief Medical Officers
    • Meet the Medics
    • Interim Chief Medical Officer
    • Medical Monitoring
    • Scientific and Medical Advice
    • Support for Medical Directors and Chief Medical Officers
    • Meet the Medics
    • Clinical Operations
    • Biostatistics
    • Clinical Project Management
    • Clinical Site Monitoring
    • Clinical Study Start-Up Support
    • Biostatistics
    • Clinical Project Management
    • Clinical Site Monitoring
    • Clinical Study Start-Up Support
    • Product Development
    • Investor Readiness
    • Investor Readiness
    • Pharmaceutical Due Diligence
    • Early Access Programs and Real-World Data Collection
    Why Boyds?

    Integrated drug development expertise, from concept to patient.

    • Explore our approach
  • Latest
    Conversations in Drug Development

    Latest Podcast

    Listen to the latest podcast episode of Conversation in Drug Development

    • News
    • Blogs
    • Case Studies
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast
    • Events
    • Podcast
  • Regulatory Updates
  • Resources

    Regulatory Updates

    Subscribe to the Regulatory Intelligence Digest to receive the latest guidance in medicines regulations

    Subscribe
    • Resources
    • Factsheets
    • Resources
    • Factsheets
    • Publications
    • Webinars
    • Publications
    • Webinars
Contact Us

Providing support for a phase 2 study in patients with metastatic breast cancer in the UK and EU

Boyds provided services to assist an EU Sponsor with the set up and ongoing site management of a study in patients with advanced metastatic breast cancer in the UK and Spain.

Contact Us

UK +44 (0)1270 270010
US +1 800 982 7431
E info@boydconsultants.com

Twitter Linkedin Youtube Spotify Apple

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical and Medical Affairs
  • Pharma Due Diligence
  • Regulatory Operations

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

Boyds is the trading name of Boyds International Life Sciences Group Limited registered in England and Wales. Registered Number: 13521126 © Boyds 2026. All Rights Reserved.

Privacy Policy      Contact

arrow